Marvin J Van Every, MD | |
1836 South Ave, La Crosse, WI 54601-5429 | |
(608) 782-7300 | |
Not Available |
Full Name | Marvin J Van Every |
---|---|
Gender | Male |
Speciality | Urology |
Location | 1836 South Ave, La Crosse, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962407809 | NPI | - | NPPES |
31399400 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 29231 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Marvin J Van Every, MD 1836 South Ave, La Crosse, WI 54601-5429 Ph: (608) 782-7300 | Marvin J Van Every, MD 1836 South Ave, La Crosse, WI 54601-5429 Ph: (608) 782-7300 |
News Archive
Reporting in the journal Nature , researchers led by Emad Alnemri, Ph.D., professor of Biochemistry and Molecular Biology in the Kimmel Cancer Center at Jefferson, discovered a key protein component involved in inflammation.
People with low incomes are more likely to be under stress than their wealthier peers
The increased demand for primary care services expected to result from the Affordable Care Act (ACA) may be felt strongly in rural areas. While studies have found that the quality of care delivered to rural patients is as good or better than that available in urban areas, the belief persists that top-quality primary care is only available in big cities.
The Associated Press: "For the first time since leaving medical school, many doctors are having to take tests to renew board certification in their fields — 147 specialties from dermatology to obstetrics. Any doctor can deliver a baby, treat cancer, or declare himself a cardiologist. Certification means the doctor had special training in that field and passed an exam to prove knowledge of it.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for its doxorubicin targeted conjugate compound, AEZS-108, in luteinizing hormone releasing hormone (LHRH) receptor positive urothelial (bladder) cancer.
› Verified 6 days ago
Michael J Price, MD Urology Medicare: Medicare Enrolled Practice Location: 800 West Ave S, La Crosse, WI 54601 Phone: 608-392-9883 Fax: 608-392-6010 | |
Dr. Scott Christian Pate, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 800 West Ave S, La Crosse, WI 54601 Phone: 608-785-0940 | |
Joseph M Endrizzi, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300 Fax: 608-775-4467 | |
Thomas A Londergan, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300 | |
Dr. Chris A Hofland, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1836 South Ave, La Crosse, WI 54601 Phone: 608-782-7300 |